The best indicator for Domino's (DPZ)
We backtested 20 indicators across daily, weekly and hourly charts on real Domino's (DPZ) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Domino's (DPZ) over ~21.9 years — trailing buy-and-hold by 3.0% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Daily | 16.9% | 0.74 | -42.4% | 45.0% | 40 | -3.0% |
| 2 | EMA 50/200 Cross ✓ | Daily | 16.2% | 0.72 | -44.5% | 53.8% | 13 | -3.6% |
| 3 | RSI Trend (>50) ✓ | Daily | 11.8% | 0.58 | -57.2% | 44.5% | 265 | -8.1% |
| 4 | SMA 50/200 Cross ✓ | Daily | 14.0% | 0.65 | -48.3% | 61.5% | 13 | -5.9% |
| 5 | ADX / DMI ✓ | Daily | 9.0% | 0.55 | -35.3% | 46.3% | 149 | -10.9% |
| 6 | RSI Trend (>50) ✓ | Weekly | 11.2% | 0.54 | -65.8% | 53.7% | 54 | -8.4% |
| 7 | Donchian Midline ✓ | Weekly | 10.8% | 0.52 | -72.5% | 47.2% | 53 | -8.8% |
| 8 | EMA-10 Trend ✓ | Weekly | 10.2% | 0.51 | -67.1% | 50.0% | 88 | -9.4% |
| 9 | Williams %R ✓ | Weekly | 6.7% | 0.49 | -34.0% | 75.0% | 24 | -12.9% |
| 10 | Donchian Midline ✓ | Daily | 9.2% | 0.48 | -57.5% | 44.7% | 302 | -10.7% |
| 11 | Donchian Breakout | Weekly | 8.8% | 0.48 | -49.8% | 75.0% | 16 | -10.8% |
| 12 | Donchian Breakout ✓ | Daily | 7.9% | 0.46 | -45.0% | 51.6% | 93 | -12.0% |
| 13 | Rate of Change ✓ | Daily | 8.4% | 0.46 | -44.2% | 47.9% | 378 | -11.4% |
| 14 | MACD ✓ | Daily | 7.8% | 0.43 | -79.7% | 41.4% | 220 | -12.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Domino's (DPZ), EMA 20/50 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.